Finally, PSELT showed a clear tendency to preserve dopamine levels in the Str measured at day 7 post-treatment, but the difference between the PSELT/MPTP- and MPTP-treated groups did not reach statistical significance ( Fig. 5 J).
← all excerpts
Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models.
2
—
—
The sentences
In fact, PSELT exhibited a clear trend to normalize dopamine levels in the striatum after 7 days of treatment but the differences were not statistically significant likely due to the compensation phenomena.